Post-COVID-19 condition. Clinical-epidemiological profile in workers from different occupational sectors in Havana
Keywords:
COVID 19, postCOVID-19 condition, working population, occupational healthAbstract
Introduction: COVID-19 became a multidimensional health problem, which not only culminated in the diagnosis and treatment of patients and achieving control of the pandemic, but went a little further with consequences at an organic and functional level in the patients. individuals once the acute phase of the disease has ended, defining certain post-COVID-19 conditions that could limit the workers' aptitude for the specific activity they carry out.
Objective: Identify clinical-epidemiological characteristics and fitness for work in workers convalescing from COVID-19.
Material and Methods: A cross-sectional descriptive study was carried out on workers from Havana treated in the multidisciplinary consultation of the National Institute of Workers' Health for convalescents from COVID-19 during the period from May 2021 to September 2022. The population was made up of 222 workers from different occupational sectors.
Results: The occupational sectors predominated: health (70.7%); construction (8.6%) and gastronomy and commerce (8.1%); the clinical form uncomplicated disease (minimally symptomatic) (57.2%). The symptoms that persisted were dyspnea (33.8%), weakness in lower limbs (31.1%), and arthralgia (23%). High blood pressure (63.5%), obesity (29.1% and bronchial asthma (20.2%) prevailed as the main comorbidities. All workers were suitable for the job.
Conclusions: The persistence of post-COVID-19 symptoms is common. Female sex, age from 50 to 59 years and high blood pressure are associated factors. Accurate information is provided about workers from different occupational sectors in Cuba who suffered from persistent COVID-19, for which there is no history in the country
Downloads
References
Occupational Safety and Health Administration. Guidance on preparing workplaces for COVID-19. 2020 [acceso 12/03/2021]. Disponible en: https://www.osha.gov/sites/default/files/publications/OSHA3990.pdf.
Organización Internacional del Trabajo. La COVID-19 y el mundo del trabajo.2020 [acceso 07/07/2021]. Disponible en: https://www.ilo.org/global/topics/coronavirus/impacts-and-responses/WCMS_767045/lang--es/index.htm
Word Health Organization. A clinical case definition of post COVID - 19 condition by a Delphi consensus. 2021 [acceso18/10/21]. Disponible en: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
Albizu-Campos EJ. Cuba. Una mirada a la población económicamente activa. Rev Nov Pob. 2020 [acceso 10/06/22];16(32):132-81. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-40782020000200132&lng=es&nrm=iso
Herrera G, Arellano M, Juárez G, Contreras A. Persistencia de síntomas en pacientes después de la enfermedad por coronavirus (COVID-19) en un hospital de tercer nivel de Puebla, México. Med Int Méx. 2020;36(6):789-93. DOI: https://doi.org/10.24245/mim.v36i6.4581
Darley D, Dore G, Cysique L, Wilhelm K, Andresen D, Tonga K, et al. Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. Med J Aust. 2021; 214(6):279-80. DOI: https://doi.org/10.5694/mja2.50963.
Ruiz R, Terán M, Zambrano M, Poleo G. PostCOVID-19: caracterización clínica y paraclínica. Med Interna (Caracas). 2023 [acceso18/10/23];39(2):85-98. Disponible en: https://svmi.web.ve/wp-content/uploads/2023/08/Revista-Volumen-39-na-2_SVMI-1.pdf
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020;20(5):533–4. DOI: http://dx.doi.org/10.1016/S1473-3099(20)30120-1.
Proal A, Van E.Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021 Jun 23;12:698169. DOI: https://doi.org/10.3389/fmicb.2021.698169
Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Long COVID or post COVID-19 syndrome. Mult Scler Relat Disord. 2021 Oct;55:103268. DOI: https://doi.org/10.1016/j.msard.2021.103268
Huang C, Huang L, Wang Y. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32. DOI: https://doi.org/10.1016/s0140-6736(20)32656-8
Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021 [acceso 12/03/22]11:e048391. Disponible en: https://bmjopen.bmj.com/content/bmjopen/11/3/e048391.full.pdf
Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. The Writing Committee for the COMEBAC Study Group. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA 2021;325(15):1525–34. DOI: http://doi.org/10.1001/jama.2021.3331.
Codas ME, Torres V, Barrios G. COVID largo, síntomas más frecuentes en pacientes post COVID-19, Paraguay, 2021. Rev. virtual Soc. Parag. Med. Int. sept 2022;9 (2):75-83. DOI: https://doi.org/10.18004/rvspmi/2312-3893/2022.09.02.75.
Carfi A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5. DOI: : https://doi.org/10.18004/rvspmi/2312-3893/2022.09.02.75.
Chopra V, Flanders S, O'Malley M, Malani A, Prescott H. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576–8. DOI: http://dx.doi.org/10.7326/M20-5661.
Goërtz Y, Van Herck M, Delbressine J, Vaes A, Meys R, Machado F, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. ERJ Open Res. 2020;6(4):00542–2020. DOI: http://dx.doi.org/10.1183/23120541.00542-2020
Rodríguez L, Armenteros del O, Caballero S, Bilbao F. La persistencia de síntomas de la COVID-19 y su diagnóstico en la primera ola de la pandemia en España. Med Gen Fam. 2021;12(2). DOI: http://dx.doi.org/10.24038/mgyf.2021.009
Santana L, Perdomo H, Amador R. Condición postCOVID-19 en trabajadores de la salud. La Habana. Un año de seguimiento Rev haban cienc méd. 2022 [acceso 21/1/2023];21(6). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/5119
López-Sampalo A, Bernal-López M, Gómez-Huelgas R. Síndrome de COVID-19 persistente. Una revisión narrativa [Persistent COVID-19 syndrome. A narrative review]. Rev Clin Esp. Apr 2022(4):241-50. Spanish. DOI: https://doi.org/10.1016%2Fj.rce.2021.10.003
Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259–64. DOI: https://doi.org/10.1038/s41586-021-03553-9
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C; French COVID cohort study and investigators groups. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021 Jul;27(7):1041.e1-1041.e4. DOI: https://doi.org/10.1016/j.cmi.2021.03.012
Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. Feb 2021;93(2):1013-22. DOI: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26368
Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect.2020;81(6):e4–6. DOI: http://dx.doi.org/10.1016/j.jinf.2020.08.029
Tenforde M, Kim S, Lindsell C, Billig R, Shapiro N,Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, march-June 2020. MMWR Morb Mortal Wkly Rep 2020;69(30):993–8. DOI: : http://dx.doi.org/10.15585/mmwr.mm6930e1
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0) Esta licencia permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (componente BY o atribución). Coincidente con la política de Acceso Abierto, no se podrán hacer usos comerciales de los contenidos publicados por esta revista (componente NC). Se permitirán las obras derivadas (remezcla, transformación o creación a partir de la obra original), siempre y cuando sean distribuidas bajo la misma licencia de la obra original (componente SA).
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
